Novacyt S.A. (FRA:NYZ)
0.3845
-0.0105 (-2.66%)
At close: Jan 30, 2026
Novacyt Market Cap
Novacyt has a market cap or net worth of €28.91 million as of January 30, 2026. Its market cap has decreased by -32.83% in one year.
Market Cap
28.91M
Enterprise Value
14.01M
Revenue
22.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.38
Market Cap Chart
Since October 12, 2012, Novacyt's market cap has increased from 23.55M to 28.91M, an increase of 22.73%. That is a compound annual growth rate of 1.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 28.91M | 4.85% |
| Dec 31, 2025 | 27.57M | -35.08% |
| Dec 31, 2024 | 42.47M | -15.60% |
| Dec 29, 2023 | 50.32M | -42.02% |
| Dec 30, 2022 | 86.78M | -71.94% |
| Dec 31, 2021 | 309.30M | -55.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- | 40.70M |
| U.C.A. Aktiengesellschaft | 40.20M |
| OTRS AG | 36.22M |
| edding AG | 35.48M |
| Readcrest Capital AG | 32.13M |
| Weng Fine Art AG | 29.08M |
| Biomark Diagnostics | 28.58M |
| Rubean AG | 27.29M |